Y-mAbs Therapeutics
YMAB
YMAB
98 hedge funds and large institutions have $107M invested in Y-mAbs Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 36 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
+3
Holders Change %
+3.16%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
31
Reduced
36
Closed
6
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
-$9K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$2.26M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
$4.42M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
$1.32M |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
$748K |
| 5 |
D.E. Shaw & Co
New York
|
$7.35M |
